NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Effect of Obesity on Contralateral Suppression in Patients With Multiple Sclerosis
The Effect of Obesity on Contralateral Suppression in Patients With Multiple Sclerosis

NCT07136311

CompletedNA

Sponsor: Ondokuz Mayıs University

Conditions: Multiple Sclerosis, Obesity, Hearing Loss

Interventions: DPOAE with Contralateral Suppression

Countries: Turkey (Türkiye)

This study investigates how obesity may affect the auditory system in individuals with Multiple Sclerosis (MS). Specifically, it examines the brain's ability to process and suppress sounds (contralateral suppression). The test is painless and brief. It provides information about the condition of the auditory nerve pathways. The goal is to better understand how obesity may influence this system and to improve follow-up and support for individuals with MS.

Eligibility overview

Sex: ALL

Age: 18 Years to 50 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Eligibility Criteria Minimum Age: 18 Years Maximum Age: 50 Years Sex: All Gender Based: No Accepts Healthy Volunteers: No

Inclusion Criteria:

Ability to cooperate with the applied scales and auditory tests

Normal findings in otoscopic examination (ear, nose, and throat evaluation)

Absence of any neurological, psychiatric, or metabolic disease other than Multiple Sclerosis (MS)

No history of significant noise exposure

For female participants: not pregnant and not in the menstrual period

Exclusion Criteria:

Presence of active middle ear pathology (e.g., otitis media, tympanic membrane perforation)

Abnormal tympanometric findings

Hearing loss exceeding 20 dB HL at any frequency between 500-4000 Hz

Neurological or psychiatric disorders other than MS

History of ear surgery or otologic trauma

Use of medications known to affect auditory function (e.g., ototoxic drugs)

Inability to cooperate with audiological testing

Pregnancy

Diagnosis of metabolic or endocrine disorders (e.g., uncontrolled diabetes, thyroid dysfunction)

Body Mass Index (BMI) below 18.5 (underweight) or above 40 (morbid obesity)
Locations (1)
  • Samsun, Turkey (Türkiye)